483 Roundup: FDA Cites Six Firms for Quality Failures By Sam | April 15, 2020 Six devicemakers drew the FDA’s attention for lax validations, CAPAs, training and other failures found during agency inspections. Source: The GMP Letter Posted in The GMP Letter